Enfuvirtida: primer fármaco de una nueva familia de antirretrovirales
Leído
7281
Vecesse ha leído el artículo
3510
Total PDF
3771
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 67 | 30 | 97 |
| 2025 10 | 89 | 53 | 142 |
| 2025 9 | 72 | 32 | 104 |
| 2025 8 | 65 | 68 | 133 |
| 2025 7 | 44 | 49 | 93 |
| 2025 6 | 62 | 52 | 114 |
| 2025 5 | 81 | 69 | 150 |
| 2025 4 | 78 | 72 | 150 |
| 2025 3 | 86 | 59 | 145 |
| 2025 2 | 50 | 58 | 108 |
| 2025 1 | 37 | 60 | 97 |
| 2024 12 | 65 | 55 | 120 |
| 2024 11 | 67 | 49 | 116 |
| 2024 10 | 58 | 48 | 106 |
| 2024 9 | 42 | 70 | 112 |
| 2024 8 | 34 | 104 | 138 |
| 2024 7 | 44 | 131 | 175 |
| 2024 6 | 37 | 60 | 97 |
| 2024 5 | 54 | 30 | 84 |
| 2024 4 | 37 | 39 | 76 |
| 2024 3 | 38 | 47 | 85 |
| 2024 2 | 28 | 54 | 82 |
| 2024 1 | 39 | 52 | 91 |
| 2023 12 | 39 | 49 | 88 |
| 2023 11 | 34 | 61 | 95 |
| 2023 10 | 39 | 30 | 69 |
| 2023 9 | 26 | 21 | 47 |
| 2023 8 | 39 | 12 | 51 |
| 2023 7 | 30 | 25 | 55 |
| 2023 6 | 25 | 18 | 43 |
| 2023 5 | 52 | 59 | 111 |
| 2023 4 | 28 | 28 | 56 |
| 2023 3 | 45 | 58 | 103 |
| 2023 2 | 17 | 18 | 35 |
| 2022 1 | 31 | 13 | 44 |
| 2022 12 | 28 | 17 | 45 |
| 2022 11 | 34 | 13 | 47 |
| 2022 10 | 24 | 12 | 36 |
| 2022 9 | 30 | 26 | 56 |
| 2022 8 | 31 | 18 | 49 |
| 2022 7 | 30 | 15 | 45 |
| 2022 6 | 30 | 25 | 55 |
| 2022 5 | 46 | 21 | 67 |
| 2022 4 | 39 | 13 | 52 |
| 2022 3 | 36 | 15 | 51 |
| 2022 2 | 40 | 10 | 50 |
| 2021 1 | 77 | 16 | 93 |
| 2021 12 | 32 | 16 | 48 |
| 2021 11 | 31 | 10 | 41 |
| 2021 10 | 39 | 15 | 54 |
| 2021 9 | 25 | 11 | 36 |
| 2021 8 | 23 | 7 | 30 |
| 2021 7 | 16 | 4 | 20 |
| 2021 6 | 14 | 8 | 22 |
| 2021 5 | 13 | 4 | 17 |
| 2021 4 | 31 | 19 | 50 |
| 2021 3 | 32 | 14 | 46 |
| 2021 2 | 18 | 7 | 25 |
| 2020 1 | 16 | 14 | 30 |
| 2020 12 | 26 | 10 | 36 |
| 2020 11 | 48 | 8 | 56 |
| 2020 10 | 30 | 9 | 39 |
| 2020 9 | 16 | 7 | 23 |
| 2020 8 | 16 | 13 | 29 |
| 2020 7 | 9 | 10 | 19 |
| 2020 6 | 8 | 12 | 20 |
| 2020 5 | 8 | 9 | 17 |
| 2020 4 | 14 | 2 | 16 |
| 2020 3 | 6 | 14 | 20 |
| 2020 2 | 11 | 3 | 14 |
| 2020 1 | 9 | 16 | 25 |
| 2019 12 | 37 | 27 | 64 |
| 2019 11 | 6 | 3 | 9 |
| 2019 10 | 10 | 11 | 21 |
| 2019 9 | 21 | 12 | 33 |
| 2019 8 | 9 | 11 | 20 |
| 2019 7 | 20 | 13 | 33 |
| 2019 6 | 42 | 39 | 81 |
| 2019 5 | 76 | 70 | 146 |
| 2019 4 | 30 | 81 | 111 |
| 2019 3 | 1 | 19 | 20 |
| 2019 2 | 6 | 22 | 28 |
| 2019 1 | 1 | 17 | 18 |
| 2018 12 | 4 | 19 | 23 |
| 2018 11 | 2 | 11 | 13 |
| 2018 10 | 8 | 20 | 28 |
| 2018 9 | 3 | 7 | 10 |
| 2018 8 | 1 | 21 | 22 |
| 2018 7 | 1 | 20 | 21 |
| 2018 6 | 0 | 12 | 12 |
| 2018 5 | 5 | 4 | 9 |
| 2018 4 | 2 | 5 | 7 |
| 2018 3 | 0 | 1 | 1 |
| 2018 2 | 3 | 0 | 3 |
| 2018 1 | 3 | 2 | 5 |
| 2017 12 | 0 | 1 | 1 |
| 2017 11 | 4 | 2 | 6 |
| 2017 10 | 2 | 2 | 4 |
| 2017 9 | 1 | 8 | 9 |
| 2017 8 | 2 | 6 | 8 |
| 2017 7 | 4 | 17 | 21 |
| 2017 6 | 16 | 41 | 57 |
| 2017 5 | 7 | 33 | 40 |
| 2017 4 | 6 | 45 | 51 |
| 2017 3 | 9 | 71 | 80 |
| 2017 2 | 8 | 43 | 51 |
| 2016 1 | 5 | 16 | 21 |
| 2016 12 | 14 | 21 | 35 |
| 2016 11 | 32 | 45 | 77 |
| 2016 10 | 17 | 56 | 73 |
| 2016 9 | 15 | 52 | 67 |
| 2016 8 | 20 | 21 | 41 |
| 2016 7 | 20 | 27 | 47 |
| 2016 6 | 21 | 40 | 61 |
| 2016 5 | 16 | 35 | 51 |
| 2016 4 | 13 | 57 | 70 |
| 2016 3 | 20 | 26 | 46 |
| 2016 2 | 7 | 22 | 29 |
| 2015 1 | 12 | 21 | 33 |
| 2015 12 | 3 | 25 | 28 |
| 2015 11 | 15 | 27 | 42 |
| 2015 10 | 13 | 19 | 32 |
| 2015 9 | 9 | 13 | 22 |
| 2015 8 | 10 | 6 | 16 |
| 2015 7 | 10 | 11 | 21 |
| 2015 6 | 3 | 9 | 12 |
| 2015 5 | 8 | 8 | 16 |
| 2015 4 | 7 | 11 | 18 |
| 2015 3 | 7 | 6 | 13 |
| 2015 2 | 4 | 6 | 10 |
| 2015 1 | 12 | 5 | 17 |
| 2014 12 | 16 | 4 | 20 |
| 2014 11 | 16 | 2 | 18 |
| 2014 10 | 11 | 4 | 15 |
| 2014 9 | 13 | 1 | 14 |
| 2014 8 | 11 | 1 | 12 |
| 2014 7 | 15 | 2 | 17 |
| 2014 6 | 14 | 1 | 15 |
| 2014 5 | 13 | 1 | 14 |
| 2014 4 | 11 | 1 | 12 |
| 2014 3 | 9 | 1 | 10 |
| 2014 2 | 14 | 2 | 16 |
| 2014 1 | 10 | 1 | 11 |
| 2013 12 | 19 | 2 | 21 |
| 2013 11 | 12 | 2 | 14 |
| 2013 10 | 19 | 1 | 20 |
| 2013 9 | 12 | 2 | 14 |
| 2013 8 | 10 | 3 | 13 |
| 2013 7 | 10 | 2 | 12 |
| 2005 11 | 258 | 0 | 258 |
Mostrar todo
